Journal of Diagnostic Pathology: Open Access

ISSN: ISSN
1758-2008 (Print )
1758-2016 (Electronic)

Journal of Diagnostic Pathology: Open Access

Journal of Diagnostic Pathology: Open Access (JDPOA) is a peer-reviewed, open-access journal dedicated to advancing the field of diagnostic pathology through cutting-edge research and clinical applications. The journal aims to serve as a global platform for pathologists, laboratory scientists, and clinicians, providing insights into novel diagnostic techniques, histopathological findings, and emerging technologies in disease detection. JDPOA focuses on integrating traditional pathology with modern innovations such as molecular diagnostics, artificial intelligence, and digital pathology to enhance the accuracy and efficiency of disease diagnosis.

The scope of JDPOA includes but is not limited to histopathology, cytopathology, molecular pathology, immunohistochemistry, hematopathology, forensic pathology, neuropathology, dermatopathology, and microbiological pathology. The journal also emphasizes advancements in digital pathology, computational imaging, and the role of artificial intelligence in diagnostic workflows. JDPOA welcomes high-quality original research, systematic reviews, case reports, and technical advancements that contribute to precision medicine and improved patient outcomes. Through its open-access policy, the journal ensures widespread dissemination of knowledge, fostering collaboration among researchers, clinicians, and diagnostic laboratories worldwide.

Histopathology
Histopathology is the microscopic study of diseased tissues to identify structural abnormalities and cellular changes that indicate pathology. It plays a fundamental role in diagnosing various conditions, particularly cancers, by examining tissue sections stained with hematoxylin and eosin (H&E) or immunohistochemical markers. By providing detailed morphological insights, histopathology aids in understanding disease progression, prognosis, and treatment responses. It remains a cornerstone of pathology, guiding clinicians in making evidence-based medical decisions.

Cytopathology
Cytopathology involves the microscopic examination of individual cells extracted from tissues or bodily fluids to detect malignancies, infections, and inflammatory conditions. It is widely used in diagnostic techniques such as the Pap smear for cervical cancer screening and fine-needle aspiration (FNA) biopsies for tumor diagnosis. Compared to histopathology, cytopathology offers a less invasive approach to disease detection and is crucial for early diagnosis and monitoring of various pathological conditions.

Molecular Diagnostics
Molecular diagnostics involves the analysis of genetic, proteomic, and biochemical markers to identify diseases at the molecular level. Techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH) are used to detect mutations, infections, and hereditary conditions. Molecular pathology has transformed cancer diagnostics by enabling personalized medicine approaches, allowing targeted therapies based on specific genetic alterations in tumors.

Immunohistochemistry (IHC)
Immunohistochemistry (IHC) is a technique that uses antibodies to detect specific antigens in tissue samples, helping pathologists differentiate between types of cancers and other diseases. By visualizing protein expression patterns, IHC assists in diagnosing lymphoma subtypes, identifying hormone receptor status in breast cancer, and detecting infectious agents in tissues. This technique has become an essential tool in both research and clinical diagnostics, contributing to precise disease classification and treatment selection.

Digital Pathology
Digital pathology refers to the digitization of glass slides for remote viewing, storage, and analysis using high-resolution scanners and artificial intelligence (AI). This technology enables pathologists to assess tissue samples virtually, improving diagnostic accuracy, efficiency, and collaboration among experts. AI-driven image analysis in digital pathology assists in pattern recognition, automated quantification of biomarkers, and early disease detection, revolutionizing the field of diagnostic pathology.

Hematopathology
Hematopathology focuses on the study of diseases affecting the blood, bone marrow, and lymphatic system. It encompasses the diagnosis of leukemias, lymphomas, and anemias using specialized staining techniques, flow cytometry, and molecular testing. Accurate hematopathologic assessment is critical for classifying hematologic malignancies and guiding appropriate treatment strategies such as chemotherapy, immunotherapy, and bone marrow transplantation.

Forensic Pathology
Forensic pathology applies pathological principles to legal investigations, primarily in determining the cause and manner of death. Autopsies conducted by forensic pathologists provide critical insights into homicide, suicide, accidental deaths, and natural diseases. Advanced techniques such as toxicology screening, histopathological analysis, and post-mortem imaging play a crucial role in forensic investigations, aiding law enforcement and judicial systems in criminal and civil cases.

Cancer Diagnostics
Cancer diagnostics involves various techniques to detect and classify malignancies, including imaging, histopathology, cytology, molecular testing, and biomarker analysis. Early and accurate cancer diagnosis is essential for improving survival rates and guiding treatment decisions. Techniques such as liquid biopsy, circulating tumor DNA (ctDNA) analysis, and AI-assisted image analysis are emerging as promising tools in precision oncology, offering non-invasive and highly sensitive diagnostic alternatives.

Biomarkers in Disease Detection
Biomarkers are measurable biological indicators used for disease diagnosis, prognosis, and treatment monitoring. These can include proteins, genetic mutations, and metabolic signatures that reflect disease processes. In pathology, biomarker testing is widely applied in cancer, neurodegenerative disorders, and infectious diseases. Companion diagnostics, which use biomarkers to determine treatment responses, have become integral in personalized medicine and targeted therapies.

Microbiological Pathology
Microbiological pathology focuses on diagnosing infectious diseases caused by bacteria, viruses, fungi, and parasites. Techniques such as Gram staining, culture methods, polymerase chain reaction (PCR), and serological assays are used to detect and identify pathogens. Advances in molecular microbiology and metagenomics have improved the speed and accuracy of infectious disease diagnostics, aiding in outbreak investigations and antimicrobial resistance monitoring.

Artificial Intelligence in Pathology
Artificial intelligence (AI) is revolutionizing diagnostic pathology by enhancing pattern recognition, automating image analysis, and predicting disease outcomes. Machine learning algorithms trained on large datasets assist pathologists in identifying subtle morphological changes, quantifying tumor biomarkers, and streamlining workflows. AI-powered pathology tools improve diagnostic accuracy, reduce human errors, and enable faster decision-making in clinical practice.

Neuropathology
Neuropathology is the study of diseases affecting the nervous system, including neurodegenerative disorders, brain tumors, and infectious conditions. Tissue examination from brain biopsies and autopsies helps diagnose conditions such as Alzheimer’s disease, gliomas, and multiple sclerosis. Advanced techniques such as immunohistochemistry, molecular pathology, and neuroimaging are essential for understanding the complex pathology of central and peripheral nervous system diseases.

Dermatopathology
Dermatopathology focuses on diagnosing skin diseases at the microscopic level, including inflammatory conditions, autoimmune disorders, and skin cancers such as melanoma. It combines histopathology, immunofluorescence, and molecular testing to identify skin pathologies accurately. Dermatopathologists play a crucial role in detecting early-stage melanoma and guiding treatment strategies for chronic skin conditions, improving patient outcomes.

Precision Medicine in Pathology
Precision medicine in pathology involves tailoring medical treatments to individual patients based on their genetic, molecular, and histopathological profiles. By integrating molecular diagnostics, biomarker analysis, and AI-driven pathology tools, precision medicine enhances personalized treatment strategies for cancer, genetic disorders, and infectious diseases. This approach minimizes trial-and-error treatments and optimizes therapeutic responses, revolutionizing modern healthcare.

Tissue Imaging Techniques
Tissue imaging techniques such as fluorescence microscopy, electron microscopy, and mass spectrometry imaging provide detailed insights into cellular and molecular structures within tissues. These methods are essential for studying cancer progression, neurodegenerative diseases, and metabolic disorders. Advanced imaging technologies, including 3D tissue reconstruction and multiplex immunofluorescence, enhance the understanding of disease mechanisms and facilitate accurate diagnoses.

Journal Metrics:

Impact Factor 2.19
Scimago Journal Rank (SJR) 25
SJR Total Cites 20
Source Normalized Impact per Paper (SNIP) 14.82
h-index (2023) 40
PubMed NLM ID: 101558757
Google Scholar h5 index: 32
Iindex Copernicus Value: 119.6

Publon

Indexing Sites